News
12h
Zacks.com on MSNGlobus Medical (GMED) Earnings Expected to Grow: Should You Buy?Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...
Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...
StockStory.org on MSN7d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results